The Risks of Hyaluronic Acid Injection into the Breast: An Analysis of Scientific Evidence

In modern aesthetic medicine, an increasing number of patients are turning their attention to minimally invasive methods of appearance enhancement. One such approach is the use of hyaluronic acid–based fillers for breast augmentation. At first glance, this may seem like a safe alternative to implants, requiring neither surgery nor prolonged recovery. However, accumulated scientific evidence suggests otherwise: injection-based breast augmentation carries a complex and far from risk-free safety profile.

As a physician, I consider it essential to speak openly about these risks, relying not on marketing claims but on clinical experience and evidence-based medicine.

Infectious Complications and Their Consequences
One of the most serious concerns is the risk of infection. Clinical reports describe cases in which, within the first weeks after the injection of large volumes of hyaluronic acid, patients developed pain, swelling, fever, and purulent processes.

In such situations, standard antibiotic therapy is often insufficient. Diagnostic imaging, including ultrasound and MRI, may reveal multiple abscesses within breast tissue, while treatment frequently requires complex, multi-stage surgical interventions involving removal of the filler and necrotic tissue.

This demonstrates that even a biocompatible material, when used in large volumes, can become a trigger for severe infection.

Deformities, Nodules, and Unstable Aesthetic Outcomes
Another significant issue is the unpredictability of filler distribution. Hyaluronic acid does not form a stable structural framework within breast tissue, which may lead to the formation of firm nodules, asymmetry, and contour irregularities.

Studies indicate that even minor deviations from proper technique or anatomical landmarks can result in filler migration. Consequently, the aesthetic outcome may become unstable and, in some cases, clinically problematic, requiring further corrective procedures.

Thus, a procedure often presented as controlled and predictable may, in reality, yield highly variable results.

Impact on Breast Cancer Diagnostics
The most critical concern is the impact of hyaluronic acid on oncological diagnostics. This issue is not merely aesthetic but potentially life-threatening.

Filler injected into breast tissue can create lesions that mimic tumors on mammography or MRI, or conversely, mask existing malignancies. As a result, radiological interpretation becomes significantly more challenging, increasing the risk of both false-negative and false-positive findings.

This issue has been one of the key reasons for restricting the use of stabilized hyaluronic acid for breast augmentation in several countries. It is also important to note that the filler may persist in tissues for 12–18 months or longer, meaning its impact on diagnostic accuracy can be prolonged.

Technical Considerations and Limits of Safety
Modern approaches to injection-based breast augmentation include the use of ultrasound guidance, allowing for more precise identification of anatomical layers and reducing the risk of vascular complications. Cannulas and higher-cohesivity fillers are also used to improve distribution of the material.

However, even with strict adherence to technical standards, the risks cannot be completely eliminated. This represents a fundamental difference between injection-based methods and surgical approaches, where outcomes are generally more controlled.

Considerations for Patients with Comorbid Conditions
Special attention should be given to patients with autoimmune diseases. Although hyaluronic acid is considered a relatively low-immunogenic material, hypersensitivity reactions remain possible. Furthermore, there is a lack of large-scale studies evaluating the safety of injecting large volumes of filler in this patient group.

This creates additional uncertainty and necessitates a particularly cautious approach when selecting treatment methods.

Conclusion
An analysis of current scientific evidence leads to a clear conclusion: injection of hyaluronic acid into the breast is not a fully safe procedure and is associated with a number of potentially serious complications.

Key risks that must be taken into account include:

• infectious complications, including abscess formation
• deformities, nodules, and filler migration
• challenges in breast cancer diagnostics
• limited evidence regarding long-term safety

It is important to understand that the appeal of a minimally invasive approach should not outweigh clinical reality. Decisions regarding such procedures must be based on a thorough assessment of risks and benefits, as well as on open and transparent communication between physician and patient. This approach reflects the standards of responsible and modern aesthetic medicine.